Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BLLN stock hub

BillionToOne, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BLLNis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.3B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
BLLN
In the news

Latest news · BLLN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E95.5
P25 12.3P50 18.4P75 33.1
Trailing P/E118.5
P25 14.9P50 23.2P75 38.5
ROE8.7
P25 -105.6P50 -46.5P75 -3.1
ROIC34.4
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BLLN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
211
Groups with data
11
Currency
USD
Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0002070849
Company name
BillionToOne, Inc.
Country
United States
Country code
US
Cusip
090168105
Employees
713
Enterprise value
$3.9B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Diagnostics & Research
IPO Date
2025-11-06
Isin
US0901681058
Last refreshed
2026-05-10
Market cap
$4.3B
Market cap category
Mid-Cap
Price
$92.96
Price currency
USD
Rev Per Employee
497,246.84x
Sector
Healthcare
Sic
8071
Symbol
BLLN
Website
https://www.billiontoone.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
0.58%
EV Earnings
156.06x
EV Sales Forward
8.12x
EV/EBIT
107.33x
EV/EBITDA
90.23x
EV/FCF
147.09x
EV/Sales
10.95x
FCF yield
0.62%
Forward P/E
95.45x
P/B ratio
8.45x
P/E ratio
118.54x
P/S ratio
12.06x
PS Forward
8.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
10.2%
EBITDA Margin
12.14%
FCF margin
7.44%
Gross margin
70.4%
Gross Profit
$249.6M
Gross Profit Growth
139.65%
Gross Profit Growth Q
94.25%
Net Income
$24.9M
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Pretax Margin
8.51%
Profit Margin
7.02%
Profit Per Employee
$34,891
Profitable Years
1
ROA
4.46
ROCE
5.62
ROE
8.71
ROIC
34.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
EPS Growth Quarters
3
EPS Growth Years
2
OCF Growth Q
710.61%
Revenue Growth
96.09x
Revenue Growth Q
72.68x
Revenue Growth Quarters
3x
Revenue Growth Years
2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.7
Assets
$700.7M
Cash
$537.5M
Current Assets
$624.1M
Current Liabilities
$57.2M
Debt
$144.2M
Debt EBITDA
$2.59
Debt Equity
$0.29
Debt FCF
$5.46
Equity
$505.6M
Interest Coverage
556.5
Liabilities
$195.1M
Long Term Assets
$76.6M
Long Term Liabilities
$137.9M
Net Cash
$393.3M
Net Cash By Market Cap
$9.2
Net Cash Growth
378.22%
Net Debt EBITDA
$-9.14
Net Debt Equity
$-0.78
Net Debt FCF
$-14.9
Tangible Book Value
$505.6M
Tangible Book Value Per Share
$11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
10.92
Inventory Turnover
6.37
Net Working Capital
$35.8M
Quick ratio
10.47
Working Capital
$567M
Working Capital Turnover
$0.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-214%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
50-day SMA
78.4
All Time High
138.7
All Time High Change
-32.98%
All Time High Date
2025-11-26
All Time Low
61.96
All Time Low Change
50.03%
All Time Low Date
2026-03-12
ATR
7.57
Beta1y
1.16
Ch YTD
13.59
High
94.46
High52
138.7
High52 Date
2025-11-26
High52ch
-32.98%
Low
85.1
Low52
61.96
Low52 Date
2026-03-12
Low52ch
50.03%
Ma50ch
18.58%
Premarket Change Percent
1.08
Premarket Price
$93.9
Premarket Volume
2,050
RSI
61.78
RSI Monthly
0
RSI Weekly
52.2
Sharpe ratio
0.05x
Sortino ratio
0.13
Total Return
-214%
Tr YTD
13.59
Tr1m
5.1%
Tr1w
19.96%
Tr3m
2.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

13
MetricValue
Analyst Count
7
Analyst Count Top
3
Analyst Price Target Top
$137
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$0.09
Earnings Revenue Estimate
103,635,144x
Earnings Revenue Estimate Growth
75.76x
Operating Income
$36.2M
Operating margin
10.2
Price target
$122
Price Target Change
$31.7
Price Target Change Top
$47.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
23,173,349%
Float Percent
50.38%
Net Borrowing
28,597,000
Shares Insiders
11.13%
Shares Institutions
23.13%
Shares Out
45,994,764
Shares Qo Q
34.62%
Shares Yo Y
214%
Short Float
8.37%
Short Ratio
5.79
Short Shares
4.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
$6.3M
Average Volume
577,287.8x
Bv Per Share
11
CAPEX
$-11M
Ch1m
5.1
Ch1w
19.96
Ch3m
2.59
Ch6m
-7.07
Change
0.06%
Change From Open
3.29
Close
92.9
Days Gap
-3.12
Depreciation Amortization
6,855,000
Dollar Volume
120,893,829.3
Earnings Date
2026-05-06
Earnings Time
amc
EBIT
$36.2M
EBITDA
$43M
EPS
$0.78
F Score
6
FCF
$26.4M
FCF EV Yield
0.68x
FCF Per Share
$0.57
Financing CF
319,497,000
Fiscal Year End
December
Founded
2,016
Graham Number
13.92939
Graham Upside
-85.02
Income Tax
$744,000
Investing CF
-11,046,000
Ipr
54.93
Iprfo
-7.04
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-03-11
Ma20
81.87
Ma20ch
13.55%
Net CF
345,851,000
Next Earnings Date
2026-11-07
Open
90
Optionable
Yes
P FCF Ratio
162
P OCF Ratio
114.3
Position In Range
83.97
Post Close
92.96
Postmarket Change Percent
-0.46
Postmarket Price
$92.53
Ppne
71,673,000
Pre Close
92.9
Price Date
2026-05-08
Price EBITDA
$99.37
Ptbv Ratio
8.46
Relative Volume
2.25x
Revenue
354,537,000x
SBC By Revenue
5.66x
Share Based Comp
20,051,000
Tax By Revenue
0.21x
Tax Rate
2.47%
Tr6m
-7.07%
Us State
California
Volume
1,300,493
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BLLN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BLLN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.1%
Float: +50.4% of shares outstanding
Insider ownership
+11.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+8.4%
5.8 days to cover
Y/Y dilution
+214.0%
Negative means the company is buying back shares.
Technical

BLLN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.8
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BLLN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BLLN stock rating?

BillionToOne, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BLLN analysis?

The full report lives at /stocks/BLLN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BLLN?

The latest report frames BLLN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BLLN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.